Regulation of the Mammalian Selenoprotein Thioredoxin Reductase 1 in Relation to Cellular Phenotype, Growth, and Signaling Events

Antioxidants and Redox Signaling

Volumn 6, Issue 1, 2004, Pages 41-52

  Rundlöf, Anna Klara ^a   Arnér, Elias S J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SELENIUM; SELENOPROTEIN; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; CELL FUNCTION; CELL GROWTH; CYTOSOL; ENZYME SPECIFICITY; GENE INACTIVATION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMAL; OXIDATION REDUCTION REACTION; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

MAMMALIA;

EID: 0347600941     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308604771978336     Document Type: Review

References (120)

1. Abate C, Patel L, Rauscher FD, and Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249: 1157-1161, 1990.
2. Aghib DF, Bishop JM, Ottolenghi S, Guerrasio A, Serra A, and Saglio G. A 3′ truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability. Oncogene 5: 707-711, 1990.
3. Anema SM, Walker SW, Howie AF, Arthur JR, Nicol F, and Beckett GJ. Thioredoxin reductase is the major selenoprotein expressed in human umbilical-vein endothelial cells and is regulated by protein kinase C. Biochem J 342: 111-117, 1999.
4. Anestål K and Arnér ESJ. Rapid induction of cell death by selenium compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. J Biol Chem 278: 15966-15972, 2003.
5. Arnér ESJ and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267: 6102-6109, 2000.
6. Arnér ESJ, Nordberg J, and Holmgren A. Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. Biochem Biophys Res Commun 225: 268-274, 1996.
7. Arnér ESJ, Nakamura H, Sasada T, Yodoi J, Holmgren A, and Spyrou G. Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex. Free Radic Biol Med 31: 1170-1178, 2001.
8. Asahi M, Fujii J, Takao T, Kuzuya T, Hori M, Shimonishi Y, and Taniguchi N. The oxidation of selenocysteine is involved in the inactivation of glutathione peroxidase by nitric oxide donor. J Biol Chem 272: 19152-19157, 1997.
9. Bakheet T, Frevel M, Williams BR, Greer W, and Khabar KS. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 29: 246-254, 2001.
10. Becker K, Gromer S, Schirmer RH, and Müller S. Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem 267: 6118-6125, 2000.
11. Beckman JS, and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-C1437, 1996.
12. Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, and Powis G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res 16: 3459-3466, 1996.
13. Bertini R, Howard OM, Dong HF, Oppenheim JJ, Bizzarri C, Sergi R, Caselli G, Pagliei S, Romines B, Wilshire JA, Mengozzi M, Nakamura H, Yodoi J, Pekkari K, Gurunath R, Holmgren A, Herzenberg LA, Herzenberg LA, and Ghezzi P. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J Exp Med 189: 1783-1789, 1999.
14. Björnstedt M, Kumar S, and Holmgren A. Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase. J Biol Chem 267: 8030-8034, 1992.
15. Björnstedt M, Xue J, Huang W, Akesson B, and Holmgren A. The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J Biol Chem 269: 29382-29384, 1994.
16. Björnstedt M, Hamberg M, Kumar S, Xue J, and Holmgren A. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J Biol Chem 270: 11761-11764, 1995.
17. Björnstedt M, Odlander B, Kuprin S, Claesson HE, and Holmgren A. Selenite incubated with NADPH and mammalian thioredoxin reductase yields selenide, which inhibits lipoxygenase and changes the electron spin resonance spectrum of the active site iron. Biochemistry 35: 8511-8516, 1996.
18. Blanchard RK and Cousins RJ. Differential display of intestinal mRNAs regulated by dietary zinc. Proc Natl Acad Sci U S A 93: 6863-6868, 1996.
19. Chae HZ, Kang SW, and Rhee SG. Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin. Methods Enzymol 300: 219-226, 1999.
20. Chen CY and Shyu AB. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20: 465-470, 1995.
21. Clark LC, Combs GFJ, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JLJ, Park HK, Sanders BBJ, Smith CL, and Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276: 1957-1963, 1996.
22. Fujiwara N, Fujii T, Fujii J, and Taniguchi N. Functional expression of rat thioredoxin reductase: selenocysteine insertion sequence element is essential for the active enzyme. Biochem J 340: 439-444, 1999.
23. Gabbita SP, Robinson KA, Stewart CA, Floyd RA, and Hensley K. Redox regulatory mechanisms of cellular signal transduction. Arch Biochem Biophys 376: 1-13, 2000.
24. Gallegos A, Berggren M, Gasdaska JR, and Powis G. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res 57: 4965-4970, 1997.
25. Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 20: 1657-1666, 1999.
26. Gasdaska JR, Gasdaska PY, Gallegos A, and Powis G. Human thioredoxin reductase gene localization to chromosomal position 12q23-q24.1 and mRNA distribution in human tissue. Genomics 37: 257-259, 1996.
27. Gasdaska JR, Harney JW, Gasdaska PY, Powis G, and Berry MJ. Regulation of human thioredoxin reductase expression and activity by 3′-untranslated region selenocysteine insertion sequence and mRNA instability elements. J Biol Chem 274: 25379-25385, 1999.
28. Gladyshev VN, Jeang K-T, and Stadtman TC. Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc Natl Acad Sci U S A 93: 6146-6151, 1996.
29. Gladyshev VN, Factor VM, Housseau F, and Hatfield DL. Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cells. Biochem Biophys Res Commun 251: 488-493, 1998.
30. Gopalakrishna R and Gundimeda U. Antioxidant regulation of protein kinase C in cancer prevention. J Nutr 132: 3819S-3823S, 2002.
31. Gromer S and Gross JH. Methylseleninate is a substrate rather than an inhibitor of mammalian thioredoxin reductase. Implications for the antitumor effects of selenium. J Biol Chem 277: 9701-9706, 2002.
32. Gromer S, Schirmer RH, and Becker K. The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase. FEBS Lett 412: 318-320, 1997.
33. Gromer S, Arscott LD, Williams CH, Schirmer RH, and Becker K. Human placenta thioredoxin reductase: isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem 273: 20096-20101, 1998.
34. Gromer S, Merkle H, Schirmer RH, and Becker K. Human placenta thioredoxin reductase: preparation and inhibitor studies. Methods Enzymol 347: 382-394, 2002.
35. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 389: 349-352, 1997.
36. Gunther M, Laithier M, and Brison O. A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. Mol Cell Biochem 10: 131-142, 2000.
37. Haendeler J, Hoffmann J, Tischler V, Berk BC, Zeiher AM, and Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol 4: 743-749, 2002.
38. Hansson HA, Rozell B, Stemme S, Engström Y, Thelander L, and Holmgren A. Different cellular distribution of thioredoxin and subunit MI of ribonucleotide reductase in rat tissues. Exp Cell Res 163: 363-369, 1986.
39. Hensley K, Robinson KA, Gabbita SP, Salsman S, and Floyd RA. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med 28: 1456-1462, 2000.
40. Higashikubo A, Tanaka N, Noda N, Maeda I, Yagi K, Mizoguchi T, and Nanri H. Increase in thioredoxin activity of intestinal epithelial cells mediated by oxidative stress. Biol Pharm Bull 22: 900-903, 1999.
41. Hill KE, McCollum GW, Boeglin ME, and Burk RF. Thioredoxin reductase activity is decreased by selenium deficiency. Biochem Biophys Res Commun 234: 293-295, 1997.
42. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A 94:3633-3638, 1997.
43. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, and Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem 274: 27891-27897, 1999.
44. Hofmann ER, Boyanapalli M, Lindner DJ, Weihua X, Hassel BA, Jagus R, Gutierrez PL, Kalvakolanu DV, and Hofman ER. Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid. Mol Cell Biol 18: 6493-6504, 1998.
45. Holmgren A. Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction. J Biol Chem 252: 4600-4606, 1977.
46. Holmgren A. Thioredoxin. Annu Rev Biochem 54: 237-271, 1985.
47. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966, 1989.
48. Holmgren A. Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfide. Structure 3: 239-243, 1995.
49. Howie AF, Arthur JR, Nicol F, Walker SW, Beech SG, and Beckett GJ. Identification of a 57-kilodalton selenoprotein in human thyrocytes as thioredoxin reductase and evidence that its expression is regulated through the calcium-phosphoinositol signaling pathway. J Clin Endocrinol Metab 83: 2052-2058, 1998.
50. Ikarashi M, Takahashi Y, Ishii Y, Nagata T, Asai S, and Ishikawa K. Vitamin D3 up-regulated protein 1 (VDUP1) expression in gastrointestinal cancer and its relation to stage of disease. Anticancer Res 22: 4045-4048, 2002.
51. Jensen DE, Black AR, Swick AG, and Azizkhan JC. Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter. J Cell Biochem 67: 24-31, 1997.
52. Junn E, Han SH, Im JY, Yang Y, Cho EW, Um HD, Kim DK, Lee KW, Han PL, Rhee SG, and Choi I. Vitamin D3 up-regulated protein I mediates oxidative stress via suppressing the thioredoxin function. J Immunol 164: 6287-6295, 2000.
53. Kawai H, Ota T, Suzuki F, and Tatsuka M. Molecular cloning of mouse thioredoxin reductases. Gene 242: 321-330, 2000
54. Kim YC, Masutani H, Yamaguchi Y, Itoh K, Yamamoto M, and Yodoi J. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J Biol Chem 276: 18399-18406, 2001.
55. Koishi R, Kawashima I, Yoshimura C, Sugawara M, and Serizawa N. Cloning and characterization of a novel oxidoreductase KDRF from a human bone marrow-derived stromal cell line KM-102. J Biol Chem 272: 2570-2577, 1997.
56. Kruykov GV, Kruykov VM, and Gladyshev VN. New mammalian selenocysteine-containing proteins identified with an algorithm that searches for selenocysteine insertion sequence elements. J Biol Chem 274: 33888-33897, 1999.
57. Kryukov GV, Castellano S, Novoselov SM, Lobanov AV, Zehtab O, Guigo R, and Gladyshev VN. Characterization of mammalian selenoproteomes. Science 300: 1439-1443, 2003.
58. Kumar S and Holmgren A. Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters. Carcinogenesis 20: 1761-1767, 1999.
59. Kumar S, Björnstedt M, and Holmgren A. Selenite is a substrate for calf thymus thioredoxin reductase and thioredoxin and elicits a large non-stoichiometric oxidation of NADPH in the presence of oxygen. Eur J Biochem 207: 435-439, 1992.
60. Lechner S, Müller-Ladner U, Schlottman K, Jung B, McClelland M, Rüschoff J, Welsh J, Schölmerich J, and Kullman F. Bile acids mimic oxidative stress induced upregulation of thioredoxin reductase in colon cancer cell lines. Carcinogenesis 23: 1281-1288, 2002.
61. Lee SR, Kim JR, Kwon KS, Yoon HW, Levine RL, Ginsburg A, and Rhee SG. Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J Biol Chem 274: 4722-4734, 1999.
62. Lescure A, Gautheret D, Carbon P, and Krol A. Novel selenoproteins identified in silico and in vivo by using a conserved RNA structural motif. J Biol Chem 274: 38147-38154, 1999.
63. Lewin MH, Arthur JR, Riemersma RA, Nicol F, Walker SW, Millar EM, Howie AF, and Beckett GJ. Selenium supplementation acting through the induction of thioredoxin reductase and glutathione peroxidase protects the human endothelial cell line EAhy926 from damage by lipid hydroperoxides. Biochim Biophys Acta 1593: 85-92, 2002.
64. Lickteig K, Lamb K, Brigman K, and Rizzino A. Effects of oxidation and reduction on the binding of transcription factors to cis-regulatory elements located in the FGF-4 gene. Mol Reprod Dev 44: 146-152, 1996.
65. Lin S, Cullen WR, and Thomas DJ. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem Res Toxicol 12: 924-930, 1999.
66. Lin S, Del Razo LM, Styblo M, Wang C, Cullen WR, and Thomas DJ. Arsenicals inhibit thioredoxin reductase in cultured rat hepatocytes. Chem Res Toxicol 14: 305-311, 2001.
67. Martin JL. Thioredoxin - a fold for all reasons. Structure 3: 245-250, 1995.
68. Cenas N, Nivinskas H, Anusevicius Z, Sarlauskas J, Lederer F, and Arnér ESJ. Interactions of quinones with thioredoxin reductase. A challenge to the antioxidant role of the mammalian selenoprotein. J Biol. Chem Nov 2003; 1074/10.1074/0jbc.M310292200
69. Mau B-L and Powis G. Mechanism-based inhibition of thioredoxin reductase by antitumor quinoid compounds. Biochem Pharmacol 43: 1613-1620, 1992.
70. Merrill CL, Ni H, Yoon LW, Tirmenstein MA, Narayanan P, Benavides GR, Easton MJ, Creech DR, Hu CX, McFarland DC, Hahn LM, Thomas HC, and Morgan KT. Etoxomir-induced oxidative stress in HepG2 cells detected by differential gene expression is confirmed biochemically. Toxicol Sci 68: 93-101, 2002.
71. Miller S, Walker SW, Arthur JR, Nicol F, Pickard K, Lewin MH, Howie AF, and Beckett GJ. Selenite protects human endothelial cells from oxidative damage and induces thioredoxin reductase. Clin Sci 100: 543-550, 2001.
72. Miranda-Vizuete A, Damdimopoulos AE, Pedrajas JR, Gustafsson JÅ, and Spyrou G. Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization. Eur J Biochem 261: 405-412, 1999.
73. Miranda-Vizuete A, Ljung J, Damdimopoulos AE, Gustafsson JA, Oko R, Pelto-Huikko M, and Spyrou G. Characterization of Sptrx, a novel member of the thioredoxin family specifically expressed in human spermatozoa. J Biol Chem 276: 31567-31574, 2001.
74. Moos PJ, Edes K, Cassidy P, Massuda E, and Fitzpatrick FA. Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J Biol Chem 278: 745-750, 2003.
75. Moskovitz J, Bar-Noy S, Williams WM, Requena J, Berlett BS, and Stadtman ER. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci U S A 98: 12920-12925, 2001.
76. Mostert V, Hill KE, and Burk RF. Loss of activity of the selenoenzyme thioredoxin reductase causes induction of hepatic heme oxygenase-1. FEBS Lett 541: 85-88, 2003.
77. Nakamura H, Nakamura K, and Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369, 1997.
78. Nishiyama A, Masutani H, Nakamura H, Nishinaka Y, and Yodoi J. Redox regulation by thioredoxin and thioredoxin-binding proteins. IUBMB Life 52: 29-33, 2001.
79. Nordberg J and Arnér ESJ. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31: 1287-1312, 2001.
80. Nordberg J, Zhong L, Holmgren A, and Arnér ESJ. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J Biol Chem 273: 10835-10842, 1998.
81. Oberley TD, Verwiebe E, Zhong W, Kang SW, and Rhee SG. Localization of the thioredoxin system in normal rat kidney. Free Radic Biol Med 30: 412-424, 2001.
82. Osborne SA and Tonissen KF. Genomic organisation and alternative splicing of mouse and human thioredoxin reductase 1 genes. BMC Genomics 2: 10, 2001.
83. Park YS, Fujiwara N, Koh YH, Miyamoto Y, Suzuki K, Honke K, and Taniguchi N. Induction of thioredoxin reductase gene expression by peroxynitrite in human umbilical vein endothelial cells. Biol Chem 383: 683-691, 2002.
84. Rozell B, Hansson HA, Luthman M, and Holmgren A. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol 38: 79-86, 1985.
85. Rundlöf AK, Carlsten M, Giacobini MM, and Arnér ESJ. Prominent expression of the selenoprotein thioredoxin reductase in the medullary rays of the rat kidney and thioredoxin reductase mRNA variants differing at the 5′ untranslated region. Biochem J 347: 661-668, 2000.
86. Rundlöf A-K, Carlsten M, and Arnér ESJ. The core promoter of human thioredoxin reductase 1: cloning, transcriptional activity, and Oct-1, Sp1, and Sp3 binding reveal a housekeeping-type promoter for the AU-rich element-regulated gene. J Biol Chem 376: 30542-30551, 2001.
87. Sadek CM, Damdimopoulos AE, Pelto-Huikko M, Gustafsson JÅ, Spyrou G, and Miranda-Vizuete A. Sptrx-2, a fusion protein composed of one thioredoxin and three tandemly repeated NDP-kinase domains, is expressed in human testis germ cells. Genes Cells 6: 1077-1090, 2001.
88. Sadek CM, Jimenez A, Damdimopoulos AE, Kieselbach T, Nord M, Gustafsson JÅ, Spyrou G, Davies EC, Oko R, van der Hoorn FA, and Miranda-Vizuete A. Characterization of human thioredoxin-like 2. A novel microtubule-binding thioredoxin expressed predominantly in the cilia of lung airway epithelium and spermatid manchette and axoneme. J Biol Chem 278: 13133-13142, 2003.
89. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17: 2596-2606, 1998.
90. 2+ influx-mediated suppression of vitamin D3 up-regulated protein 1 (VDUP1) mRNA in cerebellar granule neurons undergoing apoptosis. J Neurochem 78: 1267-1276, 2001.
91. Sandalova T, Zhong L, Lindqvist Y, Holmgren A, and Schneider G. Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme. Proc Natl Acad Sci U S A 98: 9533-9538, 2001.
92. Sasada T, Nakamura H, Ueda S, Sato N, Kitaoka Y, Gon Y, Takabayashi A, Spyrou G, Holmgren A, and Yodoi J. Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum (II). Free Radic Biol Med 27: 504-514, 1999.
93. Schallreuter KU, Gleason FK, and Wood JM. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochim Biophys Acta 1054: 14-20, 1990.
94. Schenk H, Klein M, Erdbrügger W, Dröge W, and Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci U S A 91: 1672-1676, 1994.
95. Schenk H, Vogt M, Dröge W, and Schulze-Osthoff K. Thioredoxin as a potent costimulus of cytokine expression. J Immunol 156: 765-771, 1996.
96. Schutze N, Bachthaler M, Lechner A, Köhrle J, and Jakob F. Identification by differential display PCR of the selenoprotein thioredoxin reductase as a 1 alpha,25(OH)2-vitamin D3-responsive gene in human osteoblasts-regulation by selenite. Biofactors 7: 299-310, 1998.
97. Schutze N, Fritsche J, Ebert-Dumig R, Schneider D, Köhrle J, Andreesen R, Kreutz M, and Jakob F. The selenoprotein thioredoxin reductase is expressed in peripheral blood monocytes and THP1 human myeloid leukemia cells-regulation by 1,25-dihydroxyvitamin D3 and selenite. Biofactors 10: 329-338, 1999.
98. Seo YR, Kelley MR, and Smith ML. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci U S A 99: 14548-14553, 2002.
99. Shao LE, Tanaka T, Gribi R, and Yu J. Thioredoxin-related regulation of NO/NOS activities. Ann N Y Acad Sci 962: 140-150, 2002.
100. Shaw G and Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667, 1986.
101. Sies H, Sharov VS, Klotz LO, and Briviba K. Glutathione peroxidase protects against peroxynitrite-mediated oxidations. J Biol Chem 272: 27812-27817, 1997.
102. Song H, Cho D, Jeon JH, Han SH, Hur DY, Kim YS, and Choi I. Vitamin D(3) up-regulating protein 1 (VDUP1) antisense DNA regulates tumorigenicity and melanogenesis of murine melanoma cells via regulating the expression of fas ligand and reactive oxygen species. Immunol Lett 86: 235-247, 2003.
103. Spyrou G, Enmark E, Miranda-Vizuete A, and Gustafsson J. Cloning and expression of a novel mammalian thioredoxin. J Biol Chem 272: 2936-2941, 1997.
104. Sun QA, Wu Y, Zappacosta F, Jeang KT, Lee BJ, Hatfield DL, and Gladyshev VN. Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J Biol Chem 274: 24522-24530, 1999.
105. Sun QA, Kirnarsky L, Sherman S, and Gladyshev VN. Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. Proc Natl Acad Sci U S A 98: 3673-3678, 2001.
106. Sun QA, Zappacosta F, Factor VM, Wirth PJ, Hatfield DL, and Gladyshev VN. Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing. J Biol Chem 276: 3106-3114, 2001.
107. Suske G. The Sp-family of transcription factors. Gene 238: 291-300, 1999.
108. Swick AG, Blake MC, Kahn JW, and Azizkhan JC. Functional analysis of GC element binding and transcription in the hamster dihydrofolate reductase gene promoter. Nucleic Acids Res 17: 9291-9304, 1989.
109. Tamura T and Stadtman TC. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci U S A 93: 1006-1011, 1996.
110. Thannickal VJ and Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028, 2000.
111. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, and Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2: 222-228, 2001.
112. Ueno M, Masutani H, Arai R J, Yamauchi A, Hirota K, Sakai T, Inamoto T, Yamaoka Y, Yodoi J, and Nikaido T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem 274: 35809-35815, 1999.
113. Ueno M, Masutani Y, Nakamura H, Masutani H, Yagi M, Yamashiro H, Kato H, Inamoto T, Yamauchi A, Takahashi R, Yamaoka Y, and Yodoi J. Possible association of thioredoxin and p53 in breast cancer. Immunol Lett 75: 15-20, 2000.
114. Vassart G and Dumont JE. The thyrotrophin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13: 61-76, 1992.
115. Wu X, Bishopric NH, Discher DJ, Murphy BJ, and Webster KA. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol 16: 1035-1046, 1996.
116. Zhang H, Li YD, Patel JM, and Block ER. Thioredoxin overexpression prevents NO-induced reduction of NO synthase activity in lung endothelial cells. Am J Physiol 19: L288-L293, 1998.
117. Zhang J, Svehlikova VV, Bao Y, Howie AF, Beckett GJ, and Williamson G. Synergy between sulforaphane and selenium in the induction of thioredoxin reductase I requires both transcriptional and translational modulation. Carcinogenesis 24: 497-503, 2003.
118. Zhong L and Holmgren A. Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. J Biol Chem 275: 18121-18128, 2000
119. Zhong L, Arnér ESJ, Ljung J, Åslund F, and Holmgren A. Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue. J Biol Chem 273: 8581-8591, 1998.
120. Zhong L, Arnér ESJ, and Holmgren A. Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence. Proc Natl Acad Sci U S A 97: 5854-5859, 2000.